Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Markowitz

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|October 1, 2004
Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interactionJoseph Markowitz, Ijen Chen, Rossi Gitti, et al.
NPJ Precision Oncology|January 12, 2026
Predicting anti-PD-1 immune checkpoint blockade response in melanoma patients with spatially aware machine learning modelsAlyssa Pybus, Raphael Kirchgaessner, Jonathan Nguyen, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2020
Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma modelBrittany L Bunch, Krithika N Kodumudi, Ellen Scott, et al.
Cancer Research|February 17, 2022
Tumor Expression Quantitative Trait Methylation Screening Reveals Distinct CpG Panels for Deconvolving Cancer Immune SignaturesXiaoqing Yu, Ling Cen, Y Ann Chen, et al.
Biochemistry|May 11, 2005
Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53Joseph Markowitz, Richard R Rustandi, Kristen M Varney, et al.
Cancers|February 27, 2026
Survival Assessment by Central Review vs. Local Investigator in Metastatic Melanoma: A Systematic Review and Meta-AnalysisIslam Eljilany, Eissa Jafari, Abdullah Alhumaid, et al.
Cancers|December 1, 2020
Multi-Omics and Informatics Analysis of FFPE Tissues Derived from Melanoma Patients with Long/Short Responses to Anti-PD1 Therapy Reveals Pathways of ResponseSaurabh K Garg, Eric A Welsh, Bin Fang, et al.
Cancers|June 28, 2023
Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell CarcinomaJulian A Marin-Acevedo, Bethany M Withycombe, Youngchul Kim, et al.
Cancers|March 29, 2023
Dichotomous Nitric Oxide-Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in MelanomaSaurabh K Garg, James Sun, Youngchul Kim, et al.
Bioinformatics and Biology Insights|May 5, 2017
Plasma MicroRNA Levels Following Resection of Metastatic MelanomaNicholas Latchana, Zachary B Abrams, J Harrison Howard, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|October 1, 2004
Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interactionJoseph Markowitz, Ijen Chen, Rossi Gitti, et al.
NPJ Precision Oncology|January 12, 2026
Predicting anti-PD-1 immune checkpoint blockade response in melanoma patients with spatially aware machine learning modelsAlyssa Pybus, Raphael Kirchgaessner, Jonathan Nguyen, et al.
Cancer Immunology, Immunotherapy : CII|June 20, 2020
Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma modelBrittany L Bunch, Krithika N Kodumudi, Ellen Scott, et al.
Cancer Research|February 17, 2022
Tumor Expression Quantitative Trait Methylation Screening Reveals Distinct CpG Panels for Deconvolving Cancer Immune SignaturesXiaoqing Yu, Ling Cen, Y Ann Chen, et al.
Biochemistry|May 11, 2005
Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53Joseph Markowitz, Richard R Rustandi, Kristen M Varney, et al.
Cancers|February 27, 2026
Survival Assessment by Central Review vs. Local Investigator in Metastatic Melanoma: A Systematic Review and Meta-AnalysisIslam Eljilany, Eissa Jafari, Abdullah Alhumaid, et al.
Cancers|December 1, 2020
Multi-Omics and Informatics Analysis of FFPE Tissues Derived from Melanoma Patients with Long/Short Responses to Anti-PD1 Therapy Reveals Pathways of ResponseSaurabh K Garg, Eric A Welsh, Bin Fang, et al.
Cancers|June 28, 2023
Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell CarcinomaJulian A Marin-Acevedo, Bethany M Withycombe, Youngchul Kim, et al.
Cancers|March 29, 2023
Dichotomous Nitric Oxide-Dependent Post-Translational Modifications of STAT1 Are Associated with Ipilimumab Benefits in MelanomaSaurabh K Garg, James Sun, Youngchul Kim, et al.
Bioinformatics and Biology Insights|May 5, 2017
Plasma MicroRNA Levels Following Resection of Metastatic MelanomaNicholas Latchana, Zachary B Abrams, J Harrison Howard, et al.
Pageof 9